Spesolimab Rapidly Resolved Capillary Leak Syndrome Associated with Generalized Pustular Psoriasis
DOI:
https://doi.org/10.2340/actadv.v105.adv-2025-0012Keywords:
spesolimab, generalized pustular psoriasis, capillary leak syndromeDownloads
References
Handfield-Jones SE, Garvey M, McGibbon DH, Black MM. Capillary leak syndrome in generalized pustular psoriasis. Br J Dermatol 1992; 127: 64. DOI: https://doi.org/10.1111/j.1365-2133.1992.tb14833.x
Fujita H, Terui T, Hayama K, Akiyama M, Ikeda S, Mabuchi T, et al. Japanese guidelines for the management and treatment of generalized pustular psoriasis: the new pathogenesis and treatment of GPP. J Dermatol 2018; 45: 1235–1270. DOI: https://doi.org/10.1111/1346-8138.14523
Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, et al. Trial of spesolimab for generalized pustular psoriasis. N Engl J Med 2021; 385: 2431–2440. DOI: https://doi.org/10.1056/NEJMoa2111563
Morita A, Tsai TF, Yee EYW, Okubo Y, Imafuku S, Zheng M, et al. Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: results from the randomized, double-blind, placebo-controlled Effisayil™ 1 study. J Dermatol 2023; 50: 183–194. DOI: https://doi.org/10.1111/1346-8138.16609
Okada Y, Kamata M, Hayashi K, Sugiura K, Tada Y. Effectiveness and safety of spesolimab in patients with generalized pustular psoriasis: a single-centre retrospective study. Acta Derm Venereol 2025; 105: adv42879. DOI: https://doi.org/10.2340/actadv.v105.42879
Published
How to Cite
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.